Roy Butcher, procurement manager at Southgate Packaging looks at the latest trends in anti-counterfeiting packaging technologies and how Covid-19 has played a major role in product innovation.
Sue Ellison, joint MD of OPM (labels and packaging) Group looks at how counterfeiting measures for pharmaceuticals packaging are being affected in a post-Brexit world.
Dr Ash Ramzan, founder and principal consultant at regulatory affairs consultancy, Woodley BioReg looks at how the key requirements of the Falsified Medicines Directive are being fulfilled by stakeholders and manufacturers.
Dr Paul Dunn, chair of the International Hologram Manufacturers Association (IHMA) considers why a product identifier initiative by itself cannot be considered an authentication solution under ISO 12931.
Gaurav Mohite, global product Manager, Track & Trace at ACG Inspection Systems discusses why aggregation is essential for helping tackle counterfeit medicines.
EPM speaks to Rami Cassis, executive chairman of pharmaceutical serialisation company Advanco and CEO of Parabellum Investments about the rise in counterfeit medicines during the Covid-19 pandemic.
Here, we sit down with Ettore Cucchetti, CEO of ACG Inspection at ACG, who discusses the success of a major company milestone, and the challenges and opportunities serialisation presents.
Arne Rehm, product manager RFID/NFC Solutions at Schreiner MediPharm, explains how smart labels with integrated RFID/NFC chips support digitalisation trends in the pharmaceutical industry.
We are now six months passed the EU FMD deadline and various organisations like EMVO have begun to ask the authorities to take out sanctions against companies that don’t comply with the FMD regulations.
